ATE39921T1 - Verfahren zur herstellung von azetidinonen mit chiralitaetszentrum. - Google Patents

Verfahren zur herstellung von azetidinonen mit chiralitaetszentrum.

Info

Publication number
ATE39921T1
ATE39921T1 AT83112377T AT83112377T ATE39921T1 AT E39921 T1 ATE39921 T1 AT E39921T1 AT 83112377 T AT83112377 T AT 83112377T AT 83112377 T AT83112377 T AT 83112377T AT E39921 T1 ATE39921 T1 AT E39921T1
Authority
AT
Austria
Prior art keywords
formula
chem
antibiotic
cir
useful
Prior art date
Application number
AT83112377T
Other languages
English (en)
Inventor
Chung-Chen Wei
Manfred Weigele
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE39921T1 publication Critical patent/ATE39921T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
AT83112377T 1982-12-09 1983-12-08 Verfahren zur herstellung von azetidinonen mit chiralitaetszentrum. ATE39921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/448,116 US4502994A (en) 1982-12-09 1982-12-09 Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
EP83112377A EP0111326B1 (de) 1982-12-09 1983-12-08 Verfahren zur Herstellung von Azetidinonen mit Chiralitätszentrum

Publications (1)

Publication Number Publication Date
ATE39921T1 true ATE39921T1 (de) 1989-01-15

Family

ID=23779065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83112377T ATE39921T1 (de) 1982-12-09 1983-12-08 Verfahren zur herstellung von azetidinonen mit chiralitaetszentrum.

Country Status (13)

Country Link
US (1) US4502994A (de)
EP (1) EP0111326B1 (de)
JP (1) JPS59112986A (de)
KR (1) KR840006997A (de)
AT (1) ATE39921T1 (de)
AU (1) AU571474B2 (de)
DE (1) DE3378911D1 (de)
DK (1) DK565883A (de)
IE (1) IE56348B1 (de)
IL (1) IL70400A (de)
NZ (1) NZ206505A (de)
PH (1) PH21054A (de)
ZA (1) ZA839108B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
US4751299A (en) * 1983-11-18 1988-06-14 Takeda Chemical Industries, Ltd. Optically active β-lactams and method of their production
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents
EP0187500B1 (de) * 1984-12-20 1993-04-28 The Upjohn Company Monobactame
US4665171A (en) 1985-07-17 1987-05-12 Harvard University Process and intermediates for β-lactam antibiotics
IT1244699B (it) * 1991-02-01 1994-08-08 Luso Farmaco Inst Processo per la preparazione di acidi 3 acilammino-4- carbamoilossimetil-2-azetidinone-l-solfonici ed intermedi per la loro preparazione
WO2016207907A1 (en) * 2015-06-25 2016-12-29 Msn Laboratories Private Limited Process for the preparation of [(1 s,2r)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1 -(phenylmethyl)propyl]-carbamic acid (3r,3as,6ar)hexahydro furo[2,3-b]furan-3-yl ester and its amorphous form
KR101798198B1 (ko) * 2017-04-13 2017-11-15 주식회사 애드홈 초음파 처리를 이용한 식물성 오일 에멀젼의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216008A (en) * 1978-05-22 1980-08-05 Hoffmann-La Roche Inc. Butenoic acid derivatives
EP0048953B1 (de) * 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-Lactam-Antibiotika
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
CA1262128A (en) * 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
ATE24726T1 (de) * 1981-10-05 1987-01-15 Squibb & Sons Inc 4-aether-derivate von 2-azetidinon-1-sulfonsaeuren.

Also Published As

Publication number Publication date
IL70400A (en) 1988-09-30
IL70400A0 (en) 1984-03-30
EP0111326A1 (de) 1984-06-20
DK565883D0 (da) 1983-12-08
ZA839108B (en) 1984-07-25
AU571474B2 (en) 1988-04-21
NZ206505A (en) 1988-01-08
PH21054A (en) 1987-07-03
US4502994A (en) 1985-03-05
KR840006997A (ko) 1984-12-04
DE3378911D1 (en) 1989-02-16
IE832883L (en) 1984-06-09
EP0111326B1 (de) 1989-01-11
IE56348B1 (en) 1991-07-03
AU2221583A (en) 1984-06-14
JPS59112986A (ja) 1984-06-29
DK565883A (da) 1984-06-10

Similar Documents

Publication Publication Date Title
ATE39921T1 (de) Verfahren zur herstellung von azetidinonen mit chiralitaetszentrum.
ES2013403A6 (es) Procedimiento para preparar derivados de cefem.
JPS5612368A (en) Optically pure heterocyclic amino acid compounds* their manufacture and their use for synthesizing drug
ES8104323A1 (es) Un procedimiento para obtener 2,6-diaminonebularinas
EA199700434A1 (ru) Циклическое соединение, способ его получения и способ получения смеси диастереомеров
CA1272726C (en) 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
DE69521012D1 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
PT89098A (pt) Processo para a preparacao de derivados de guanina
BG48694A3 (en) Method for preparing alkandiol- dicarboxilates
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
JPS554337A (en) Cephalosporin analogs
DE59104516D1 (de) Verfahren zur herstellung von aminomethanphosphonsäure und aminomethyl-phosphinsäuren.
DE3572969D1 (en) A novel process for the preparation of bestatin derivatives and intermediates thereof
ATE74380T1 (de) Verfahren zur herstellung von 2-arylpropionsaeure.
CA2013960A1 (en) Substituted dibenzofurans and methods of using same
JPS5488240A (en) Novel fortimicin a derivative
JPS5538363A (en) Preparation of optically active n-mercaptoacyl-imino acid
DE3772703D1 (de) Verfahren zur herstellung von penemen.
ATE27281T1 (de) Verfahren zur herstellung von oxanosin.
EA200100163A1 (ru) Новые производные 6-деоксиэритромицина, способ их получения и их применение в качестве лекарственных средств
ES8307254A1 (es) Un procedimiento para la preparacion de un enantiomero de beta-lactama.
RU94046014A (ru) Диаминовые соли клавулановой кислоты
ES8303428A1 (es) "un procedimiento para preparar nuevos compuestos de cefem".
ES476164A1 (es) Procedimiento para la preparacion de nuevos derivados espec-tinomicinicos.
JPS5490190A (en) Preparation of optical isomer of alpha-amino-p-hydroxybenzylpenicillin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee